Clinical Trial Update: Randomized Withdrawal Study in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 randomized withdrawal trial in schizophrenia sponsored by Vanda Pharmaceuticals; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Schizophrenia | Phase 3 | Status: RECRUITING